right, 7.25% to 9.25%, which includes our patient care programs as well as the COVID-19 vaccination. We expect diagnostic testing will continue. As you think about it as vaccines ramp up, the testing will ramp down, and normal returns in the front...
For our consumers and members impacted by COVID-19, we are providing them with continued access to quality healthcare while relieving some of the added costs and stress resulting from the pandemic. As previously announced, we waived co-pays for COVID-19 related diagnostic testing for all of o...
As we look ahead to 2021, we have received many questions on the 2020 jump off. I want to be clear, our target remains to grow mid-single digits off our baseline and we are confident in our outlook. As we typically do, the baseline removes prior year’s development and net realized c...